A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses

A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses - A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020223

Enrollment

Registered

2015-12-17

Start date

2015-12-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic solid massess

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pancreatic solid mass which is detected by EUS

Exclusion criteria

Exclusion criteria: 1)< 20years old 2)Patients whose lesions are not safely punctured by EUS 3)No informed consent

Design outcomes

Primary

Measure	Time frame
Improvement of the diagnostic accuracy by IMP3 and p53 immunohistochemical staning	—

Countries

Japan

Contacts

Public ContactJunichi Senoo

Chiba University Hospital Gastroenterology

adka2742@chiba-u.jp043-222-7171

Outcome results